Overview
Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease.
Dr. Kamble is highly rated in 17 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.
His clinical research consists of co-authoring 134 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6551 Bertner Avenue, Wt 15 Floor, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Texas MD Anderson Cancer Center
William Wierda is a Hematologist and an Oncologist in Houston, Texas. Dr. Wierda is highly rated in 28 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Office
Philip Thompson is a Hematologist and an Oncologist in Houston, Texas. Dr. Thompson is highly rated in 18 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Splenectomy.
Office
Carl Allen is a Hematologist and an Oncologist in Houston, Texas. Dr. Allen is highly rated in 9 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Rammurti Kamble
How do I make an appointment with Dr. Rammurti Kamble?
You can book an appointment with Dr. Rammurti Kamble by calling their office at 713-441-1450. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rammurti Kamble a top-rated expert for Bone Marrow Transplant?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rammurti Kamble is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rammurti Kamble specialize in?
While Dr. Rammurti Kamble is a Oncology, they have specific expertise in Bone Marrow Transplant, Multiple Myeloma, and Graft Versus Host Disease (GvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Rammurti Kamble participate in research or clinical trials?
Yes. Dr. Rammurti Kamble has published 134 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Dr. Rammurti Kamble's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rammurti Kamble accept my insurance?
Dr. Rammurti Kamble accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 713-441-1450 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantDr. Kamble isDistinguished. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Kamble isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Classical Hodgkin LymphomaDr. Kamble isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Kamble isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Hodgkin LymphomaDr. Kamble isDistinguished. Learn about Hodgkin Lymphoma.
- Multiple MyelomaDr. Kamble isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Monoblastic Leukemia (AmoL)Dr. Kamble isAdvanced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kamble isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Kamble isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Kamble isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Kamble isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Kamble isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Kamble isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Kamble isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Kamble isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.